COVID-19
| 3 min read
How a team at Pfizer turned a decade-old compound into the fastest small molecule drug for COVID-19.
| 2 min read
Enamine’s chemistry platform delivered over 2,000 novel compounds to accelerate the discovery of pre-clinical candidate ASAP-0017445.
| 6 min read
Vaxart aims to revolutionize immunization by replacing injections with easy-to-take tablets.
| 4 min read
HHS decisions on COVID-19 and flu vaccines, new therapies with encouraging results for depression and ALS, and more industry news this week.
| 5 min read
From a bladder transplant to a blood test for Alzheimer's disease, there were a lot of firsts this week. Check them out here along with more industry news.
| 4 min read
An executive order on drug manufacturing, a controversial HHS appointee, a diabetes drug for prostate cancers, and more were this week’s top industry headlines.
| 5 min read
Highlights from AACR 2025, COVID-19 vaccine flip flops, an FDA approval for a rare skin disorder, and more led biotech and pharma news this week.
| 4 min read
Landmark women’s health study loses funding, a promising antibody-drug conjugate for breast cancer, a schizophrenia drug setback, and more news from this week.
| 3 min read
Bacteria’s constant interaction with viruses has led them to evolve antiviral strategies.
| 2 min read
Rhinoviruses, the main cause of the common cold, are unique among respiratory viruses.
